Search research articles
Contact Us
Filters
Showing results (61-70 of 72) with videos related to
Page
of 8
Sort By:
Journal of Biochemistry
|
December 17, 1997
Is the cannabinoid CB1 receptor a 2-arachidonoylglycerol receptor? Structural requirements for triggering a Ca2+ transient in NG108-15 cells
T Sugiura, T Kodaka, S Kondo, et al.
Journal of the Neurological Sciences
|
April 30, 1998
Elevated serum levels of soluble E- and L-selectin in patients with human T-cell lymphotropic virus type I-associated myelopathy
A Tsujino, T Nakamura, T Furuya, et al.
Immunobiology
|
December 31, 1997
Up-regulation of iNOS mRNA expression and increased production of NO in human monoblast cell line, U937 transfected by HTLV-I tax gene
H Goto, T Nakamura, S Shirabe, et al.
Proceedings of the Association of American Physicians
|
May 1, 1997
Heightened transmigrating activity of CD4-positive T cells through reconstituted basement membrane in patients with human T-lymphotropic virus type I-associated myelopathy
T Furuya, T Nakamura, S Shirabe, et al.
The Journal of Toxicological Sciences
|
July 1, 1981
[Studies on toxicity of hydrocortisone 17-butyrate 21-propionate -4. Chronic toxicity in rats by subcutaneous administration (author's transl)]
Y Tarumoto, H Tokado, M Kimura, et al.
Journal of Neuroimmunology
|
July 15, 1998
Increased Fas-mediated cytotoxicity of CD4-positive T cells in patients with human T-lymphotropic virus type I-associated myelopathy
Y Nishiura, T Furuya, T Nakamura, et al.
Journal of the Neurological Sciences
|
October 23, 1997
Successful application of pentoxifylline in the treatment of HTLV-I associated myelopathy
S Shirabe, T Nakamura, A Tsujino, et al.
The Journal of Biological Chemistry
|
January 23, 1999
Evidence that the cannabinoid CB1 receptor is a 2-arachidonoylglycerol receptor. Structure-activity relationship of 2-arachidonoylglycerol, ether-linked analogues, and related compounds
T Sugiura, T Kodaka, S Nakane, et al.
Neurology
|
March 10, 2010
Undiminished regulatory T cells in the thymus of patients with myasthenia gravis
N Matsui, S Nakane, F Saito, et al.
Journal of Neurovirology
|
August 22, 2000
Comparative molecular analysis of HTLV-I proviral DNA in HTLV-I infected members of a family with a discordant HTLV-I-associated myelopathy in monozygotic twins
S Nakane, S Shirabe, R Moriuchi, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 72) with videos related to
Sort By:
Page
of 8
Journal of Biochemistry
|
December 17, 1997
Is the cannabinoid CB1 receptor a 2-arachidonoylglycerol receptor? Structural requirements for triggering a Ca2+ transient in NG108-15 cells
T Sugiura, T Kodaka, S Kondo, et al.
Journal of the Neurological Sciences
|
April 30, 1998
Elevated serum levels of soluble E- and L-selectin in patients with human T-cell lymphotropic virus type I-associated myelopathy
A Tsujino, T Nakamura, T Furuya, et al.
Immunobiology
|
December 31, 1997
Up-regulation of iNOS mRNA expression and increased production of NO in human monoblast cell line, U937 transfected by HTLV-I tax gene
H Goto, T Nakamura, S Shirabe, et al.
Proceedings of the Association of American Physicians
|
May 1, 1997
Heightened transmigrating activity of CD4-positive T cells through reconstituted basement membrane in patients with human T-lymphotropic virus type I-associated myelopathy
T Furuya, T Nakamura, S Shirabe, et al.
The Journal of Toxicological Sciences
|
July 1, 1981
[Studies on toxicity of hydrocortisone 17-butyrate 21-propionate -4. Chronic toxicity in rats by subcutaneous administration (author's transl)]
Y Tarumoto, H Tokado, M Kimura, et al.
Journal of Neuroimmunology
|
July 15, 1998
Increased Fas-mediated cytotoxicity of CD4-positive T cells in patients with human T-lymphotropic virus type I-associated myelopathy
Y Nishiura, T Furuya, T Nakamura, et al.
Journal of the Neurological Sciences
|
October 23, 1997
Successful application of pentoxifylline in the treatment of HTLV-I associated myelopathy
S Shirabe, T Nakamura, A Tsujino, et al.
The Journal of Biological Chemistry
|
January 23, 1999
Evidence that the cannabinoid CB1 receptor is a 2-arachidonoylglycerol receptor. Structure-activity relationship of 2-arachidonoylglycerol, ether-linked analogues, and related compounds
T Sugiura, T Kodaka, S Nakane, et al.
Neurology
|
March 10, 2010
Undiminished regulatory T cells in the thymus of patients with myasthenia gravis
N Matsui, S Nakane, F Saito, et al.
Journal of Neurovirology
|
August 22, 2000
Comparative molecular analysis of HTLV-I proviral DNA in HTLV-I infected members of a family with a discordant HTLV-I-associated myelopathy in monozygotic twins
S Nakane, S Shirabe, R Moriuchi, et al.
Page
of 8